Back to Tilray or All Oil Concentrates

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This product was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Medication Details

Brand
Tilray
Designation
T25:C0
THC Potential Range (10% Legal Variance)
25mg
CBD Potential Range (10% Legal Variance)
<1mg
Cultivated or Packaged in
Canada Flag of Canada

Stock Availability

We provide stock and pharmacy information for medical cannabis patients only. Cannabis is a controlled substance in the UK and can only be dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed here.

Best Known Status: Out of Stock

Main Importer/Distributor (Authoritative Stock)

Dispensing Pharmacies

Product DescriptionPatient Reviews

🇨🇦 About Tilray Inc

Tilray is a global leader in cannabis research, cultivation, processing and distribution. We aspire to lead, legitimize and define the future of our industry by building the world’s most trusted cannabis and hemp company.

A proud pioneer, we are the first GMP-certified medical cannabis producer to supply cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments and researchers on five continents.

Tilray's experience is unmatched worldwide. Our team of professionals on the ground in 7 countries serves tens of thousands of patients and consumers around the globe. Our GMP-certified cultivation and production facilities are among the most advanced in the world.

We are committed to scientific research that leads to an improved quality of life for patients in a time frame that matters. We partner with leading hospitals and universities to advance the clinical applications of cannabinoids.

Tilray takes tremendous pride in our customer service, patient outreach, and physician interaction. We recognize the importance of tracking potential adverse events as well as therapeutic benefits in order to ensure the safety of our patients.

Patient Reviews

Coming soon, this feature is currently under active development.

  Prescription cannabis patients struggling with affordability should be allowed to grow their own, as in Canadian Flag Canada and many American Flag American states. Agree? Sign the Government Petition.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)